Crédit d'impôt recherche Grants Arcinova with R&D Status
Arcinova has been recognised and approved by the Crédit d'impôt recherche (CIR) as an organisation undertaking R&D activities. This will bestow significant benefits upon any French customers to whom Arcinova provides a service. The recognition and approval as a ‘R&D organisation’ means that French customers of Arcinova can attract an additional 30% R&D Tax Credit when assessing their tax charge, thus reducing the customers French tax bill.
The approval covers 2019, 2020 and 2021 and will help to improve Arcinova’s competitive stance as we look to expand further into the French pharmaceutical research sector.
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.